Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers

Gynecologic Oncology

Volumn 70, Issue 1, 1998, Pages 13-16

  Maxwell, G Larry ^a   Risinger, John I ^b   Tong, Betty ^a   Shaw, Heather ^a   Barrett, J Carl ^b   Berchuck, Andrew ^a   Futreal, P Andrew ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CARCINOGENESIS; CHROMOSOME 10Q; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; ONCOGENE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0032126808     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5039     Document Type: Article

References (15)

1. Berchuck A, Carney M, Lancaster J M, Marks J, Futreal A. Familial breast-ovarian cancer syndromes: BRCA1 and 2. Clin Obstet Gynecol. 41:1998;157-166.
2. Berchuck A, Cirisano F D. Genetics of ovarian cancer. Endocrinologist. 7:1997;103-106.
3. Steck P A, Pershouse M A, Jasser S A, Yung A, Lin H, Ligon A H, Langford L A, Baumgard M L, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng D HF, Tavtigian S V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advance cancers. Nature Genet. 15:1997;356-362.
4. Li J, Yen C, Liaw D, Podysypanina K, Bose S, Wang S I, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner S H, Giovanella B C, Ittmann M, Tycko B, Hibshoosh H, Wigler M H, Parsons R. PTEN, Science. 275:1997;1943-1947.
5. Liaw D, Marsh D J, Li J, Dihia P LM, Wang S I, Zheng Z, Bose S, Call K M, Tsou H C, Peacocke M, Eng C, Parsons R. Germline mutations of thePTEN. Nature Genet. 16:1997;64-67.
6. Risinger J I, Hayes S K, Berchuck A, Barrett J C. PTEN. Cancer Res. 57:1997;4736-4738.
7. Cliby W, Ritland S, Hartmann L, Dodson M, Halling K C, Keeney G, Podratz K C, Jenkins, RB. Human epithelial ovarian cancer allelotype. Cancer Res. 53:1993;2393-2398.
8. Teng D H, Rong H, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen K L, Vinson V L, Gumpper K L, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford L A, Lee J, Gordon B M, Perhouse M A, Pollack R E, Tornos C, Troncoso P, Yung W KA, Fujii G, Berson A, Bookstein R, Bolen J B, Tavtigian S V, Steck P A. MMAC1/PTEN. Cancer Res. 57:1997;5221-5225.
9. Tashiro H, Blazes M S, Wu R, Cho K R, Bose S, Wang S I, Li J, Parsons R, Hedrick Ellenson L. Mutations inPTEN. Cancer Res. 57:1997;3935-3940.
10. Peiffer S L, Herzog T J, Tribune D J, Mutch D G, Gersell D J, Goodfellow P J. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res. 55:1995;1922-1926.
11. Lukes A, Kohler M F, Pieper C F, Kerns B J, Vick W, Bentley R, Rodriguez G C, Soper J T, Clarke-Pearson D L, Bast R C, Berchuck A. Multivariable analysis of DNA ploidy, p53 and HER-2/neu. Cancer. 73:1994;2380-2385.
12. Cairns P, Okami K, Halachimi S, Halachimi N, Esteller M, Herman J G, Jen J, Isaacs W B, Bova G S, Sidransky D. Frequent inactivation ofPTEN. Cancer Res. 57:1997;4997-5000.
13. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin A F, Zeuthen J. Disruption of the MMAC1/PTEN. Cancer Res. 57:1997;3660-3663.
14. Liu W, James C D, Fredrick L, Alderete B E, Jenkins R B. PTEN. Cancer Res. 57:1997;5254-5257.
15. Rhei E, Kang L, Bogomolniy F, Federici M G, Borgen P I, Boyd J. Mutation analysis of the putative tumor suppressor genePTEN. Cancer Res. 57:1997;3657-3659.